Search Results - "Albitar, Ferras"

  • Showing 1 - 12 results of 12
Refine Results
  1. 1

    Deep Sequencing of Cell-Free Peripheral Blood DNA as a Reliable Method for Confirming the Diagnosis of Myelodysplastic Syndrome by Albitar, Ferras, Ma, Wanlong, Diep, Kevin, De Dios, Ivan, Agersborg, Sally, Thangavelu, Maya, Brodie, Steve, Albitar, Maher

    Published in Genetic testing and molecular biomarkers (01-07-2016)
    “…Demonstrating the presence of myelodysplastic syndrome (MDS)-specific molecular abnormalities can aid in diagnosis and patient management. We explored the…”
    Get more information
    Journal Article
  2. 2

    Titanium Elastic Nailing has Superior Value to Plate Fixation of Midshaft Femur Fractures in Children 5 to 11 Years by Allen, Jerad D, Murr, Kevin, Albitar, Ferras, Jacobs, Cale, Moghadamian, Eric S, Muchow, Ryan

    Published in Journal of pediatric orthopaedics (01-03-2018)
    “…BACKGROUND:American Academy of Orthopaedic Surgeons (AAOS) Clinical Practice Guidelines for pediatric femoral shaft fractures indicate titanium elastic nails…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Cooperative genetic changes in pediatric B-cell precursor acute lymphoblastic leukemia with deletions or mutations of IKZF1 by Olsson, Linda, Albitar, Ferras, Castor, Anders, Behrendtz, Mikael, Biloglav, Andrea, Paulsson, Kajsa, Johansson, Bertil

    Published in Genes chromosomes & cancer (01-05-2015)
    “…In contrast to IKZF1 deletions (ΔIKZF1), IKZF1 sequence mutations (mutIKZF1) have been reported to be rare in B‐cell precursor acute lymphoblastic leukemia and…”
    Get full text
    Journal Article
  5. 5

    Predicting Prostate Biopsy Results Using a Panel of Plasma and Urine Biomarkers Combined in a Scoring System by Albitar, Maher, Ma, Wanlong, Lund, Lars, Albitar, Ferras, Diep, Kevin, Fritsche, Herbert A, Shore, Neal

    Published in Journal of Cancer (01-01-2016)
    “…Determining the need for prostate biopsy is frequently difficult and more objective criteria are needed to predict the presence of high grade prostate cancer…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Synonymous Polymorphisms in HOXB13 as a Protective Factor for Prostate Cancer by Albitar, Ferras, Diep, Kevin, Ma, Wanlong, Albitar, Maher

    Published in Journal of Cancer (01-01-2015)
    “…Genomic association and linkage studies, as well as epidemiological data have implicated both the HOXB13 gene and single nucleotide polymorphisms (SNPs) in the…”
    Get full text
    Journal Article
  8. 8

    Using a combination of urine and plasma biomarkers for the development of a scoring sytem that can diagnose and predict prognosis of prostate cancer by Albitar, Maher, Ma, Wanlong, Diep, Kevin, Albitar, Ferras S., Fritsche, Herbert A., Shore, Neal D.

    Published in Journal of clinical oncology (01-02-2014)
    “…Abstract only 163 Background: Relying solely on serum prostate-specific antigen (sPSA) to screen for prostate cancer (PCa) can lead to unnecessary biopsies…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Deep Sequencing of Peripheral Blood Plasma DNA As a Reliable Test for Confirming the Diagnosis of Myelodysplastic Syndrome by Albitar, Ferras, Ma, Wanlong, Diep, Kevin, De Dios, Ivan, Agersborg, Sally, Thangavelu, Maya, Brodie, Steve, Albitar, Maher

    Published in Blood (06-12-2014)
    “…▪ Background: In patients presenting with cytopenia, myelodysplastic syndrome (MDS) should be considered, but confirmation of diagnosis requires bone marrow…”
    Get full text
    Journal Article
  11. 11

    Determining Tumor Load and Biallelic Mutation in Patients with CALR Mutation Using Peripheral Blood Plasma by Diep, Kevin, Ma, Wanlong, Albitar, Ferras, De Dios, Ivan, Agersborg, Sally, Thangavelu, Maya, Brodie, Steve, Albitar, Maher

    Published in Blood (06-12-2014)
    “…Background: CALR gene is frequently mutated in patients with myeloproliferative neoplasmas (MPN). Almost all mutations are indel - some with large (>50 bp)…”
    Get full text
    Journal Article
  12. 12

    Circulating Ki-67 protein in plasma as a biomarker and prognostic indicator of acute lymphoblastic leukemia by Bruey, Jean-Marie, Kantarjian, Hagop, Estrov, Zeev, Zhang, Zhong, Ma, Wanlong, Albitar, Ferras, Abdool, Adam, Thomas, Deborah, Yeh, Chenhsiung, O’Brien, Susan, Albitar, Maher

    Published in Leukemia research (01-02-2010)
    “…Abstract Tissue-based determination of Ki-67, a marker of cellular proliferation, has shown prognostic value in solid tumors and hematological malignancies. We…”
    Get full text
    Journal Article